Hyaluronan (HA) is a polysaccharide that forms a critical component of
extracellular matrixes. It is present in high concentrations in tissu
es undergoing remodeling and morphogenesis. Serum HA is elevated in pa
tients with chronic liver disease, and this has been considered to be
caused by impaired degradation by the liver endothelial cells. We stud
ied the level of HA in the ascitic fluid and plasma from 27 patients w
ith cirrhotic ascites, These values were compared with peritoneal dial
ysate effluent (PDE) and plasma from 33 patients with uremia who were
undergoing continuous ambulatory peritoneal dialysis (CAPD), The media
n HA levels in ascitic fluid and plasma from our 26 patients with cirr
hosis were significantly higher than corresponding PDE and plasma valu
es from the 33 CAPD patients (p < 0.0001), The median peritoneal/plasm
a ratios of creatinine, albumin, and immunoglobulin G in either cirrho
tic or CAPD patients were less than unity. In contrast, the median per
itoneal/plasma ratios of HA in both groups of patients exceeded one wi
th a higher peritoneal/plasma ratio of HA in patients with cirrhosis (
p = 0.0035). A significant correlation was observed between the asciti
c level of HA and interleukin-1 beta, interleukin-6, or transforming g
rowth factor-beta. Our in vitro cell culture studies revealed that HA
is synthesized by both mesothelial cells and macrophages. We observed
an additive effect in the synthesis of HA by mesothelial cells when th
e macrophage-conditioned medium was added to the RPMI culture medium.
We conclude that a high level of HA is found in ascites from patients
with cirrhosis. Our results strongly suggest that simultaneous increas
ed synthesis of HA by the peritoneal cells and a reduction of degradat
ion by liver endothelial cells occur in these patients with cirrhosis
with ascites, This event of increased HA synthesis may be contributory
to remodeling and regeneration of the peritoneal lining.